Inventor · disambiguated record
Xuri Gao
Also filed as: GAO XURI
41 granted patents·9 pending applications·258 citations·filing 2010–2025
97Inventor score
Top patents by PatentIndex Score
50 records- 0198US11384090B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jul 12, 2022·14 cites·15 claims
- 0298US11352363B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 7, 2022·13 cites·9 claims
- 0398US11339170B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 24, 2022·17 cites·18 claims
- 0498US10189846B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2017·Granted Jan 29, 2019·25 cites·8 claims
- 0598US10179131B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2016·Granted Jan 15, 2019·27 cites·15 claims
- 0697US11596611B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2021·Granted Mar 7, 2023·5 cites·13 claims
- 0797US10428070B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Oct 1, 2019·24 cites·17 claims
- 0896US12011425B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2023·Granted Jun 18, 2024·1 cites·17 claims
- 0996US11912714B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Feb 27, 2024·6 cites·13 claims
- 1096US10952978B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Mar 23, 2021·6 cites·14 claims
- 1196US10538532B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Jan 21, 2020·17 cites·15 claims
- 1295US10729688B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2019·Granted Aug 4, 2020·11 cites·19 claims
- 1395US10179792B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2017·Granted Jan 15, 2019·17 cites·13 claims
- 1494US10640511B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted May 5, 2020·13 cites·11 claims
- 1593US10934306B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2019·Granted Mar 2, 2021·5 cites·12 claims
- 1692US10723733B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Jul 28, 2020·13 cites·13 claims
- 1792US8178531B2Antiviral agentsOR YAT SUN·Filed 2011·Granted May 15, 2012·10 cites·6 claims
- 1891US12496282B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2024·Granted Dec 16, 2025·0 cites·11 claims
- 1991US8367618B2Cyclosporin analogues for preventing or treating hepatitis C infectionENANTA PHARM INC·Filed 2010·Granted Feb 5, 2013·6 cites·13 claims
- 2085US8481483B2Cyclosporin analoguesOR YAT SUN·Filed 2010·Granted Jul 9, 2013·9 cites·21 claims
- 2185US8367053B2Cyclosporin analoguesENANTA PHARM INC·Filed 2010·Granted Feb 5, 2013·9 cites·18 claims
- 2278US8349312B2Proline substituted cyclosporin analoguesENANTA PHARM INC·Filed 2010·Granted Jan 8, 2013·4 cites·18 claims
- 2376US9156886B2Cyclosporin analogues for preventing or treating hepatitis C infectionENANTA PHARM INC·Filed 2013·Granted Oct 13, 2015·2 cites·13 claims
- 2474US12054493B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2021·Granted Aug 6, 2024·0 cites·10 claims
- 2572US8685917B2Cyclosporin analoguesGAO XURI·Filed 2010·Granted Apr 1, 2014·4 cites·18 claims
- 2668US2024327334A1Covalent Inhibitors As Antiviral AgentsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 2766US2024207224A1Macrocyclic chalcone-amide derived antiviral agentsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 2866US2025059174A1Pharmaceutical Compounds and Compositions as C-Kit Kinase InhibitorsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 2965US10702528B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2018·Granted Jul 7, 2020·0 cites·14 claims
- 3065US2020317678A1Hepatitis b antiviral agentsENANTA PHARM INC·Filed 2020·Application pending·0 cites
- 3163US12145942B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2023·Granted Nov 19, 2024·0 cites·13 claims
- 3262US2023159546A1Novel spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Application pending·0 cites
- 3362US2023295175A1Processes for the preparation of substituted spirooxindole derivativesENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 3459US12398147B2Macrocyclic spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Aug 26, 2025·0 cites·17 claims
- 3559US11976084B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 7, 2024·0 cites·16 claims
- 3658US2023115107A1Novel spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Application pending·0 cites
- 3754US11472808B2Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agentsENANTA PHARM INC·Filed 2020·Granted Oct 18, 2022·0 cites·6 claims
- 3854US9765087B2Benzimidazole derivativesENANTA PHARM INC·Filed 2014·Granted Sep 19, 2017·0 cites·18 claims
- 3952US11760755B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2020·Granted Sep 19, 2023·0 cites·13 claims
- 4052US11236111B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2020·Granted Feb 1, 2022·0 cites·7 claims
- 4152US2025313569A1Pharmaceutical Compounds And Compositions As Modulators Of MAS-Related G-Protein Receptor X2ENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 4249US9603895B2Cyclosporin analogues for preventing or treating hepatitis C infectionENANTA PHARM INC·Filed 2015·Granted Mar 28, 2017·0 cites·16 claims
- 4346US2025304600A1PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORSENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 4445US10738035B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2016·Granted Aug 11, 2020·0 cites·9 claims
- 4544US10442788B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2016·Granted Oct 15, 2019·0 cites·15 claims
- 4643US9732110B2Nucleoside and nucleotide derivativesENANTA PHARM INC·Filed 2015·Granted Aug 15, 2017·0 cites·17 claims
- 4742US9675632B2Nucleoside and nucleotide derivativesENANTA PHARM INC·Filed 2015·Granted Jun 13, 2017·0 cites·17 claims
- 4841US10301255B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2016·Granted May 28, 2019·0 cites·16 claims
- 4940US10280175B2Hepatitis B antiviral agentsENANTA PHARM INC·Filed 2017·Granted May 7, 2019·0 cites·19 claims
- 5038US10407445B2Hepatitis C virus inhibitorsENANTA PHARM INC·Filed 2016·Granted Sep 10, 2019·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Xuri Gao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →